0001140361-22-023936.txt : 20220624 0001140361-22-023936.hdr.sgml : 20220624 20220624061522 ACCESSION NUMBER: 0001140361-22-023936 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20220624 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20220624 DATE AS OF CHANGE: 20220624 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ATI Physical Therapy, Inc. CENTRAL INDEX KEY: 0001815849 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-NURSING & PERSONAL CARE FACILITIES [8050] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39439 FILM NUMBER: 221036895 BUSINESS ADDRESS: STREET 1: 790 REMINGTON BOULEVARD CITY: BOILINGBROOK STATE: IL ZIP: 60440 BUSINESS PHONE: 702-844-6111 MAIL ADDRESS: STREET 1: 790 REMINGTON BOULEVARD CITY: BOILINGBROOK STATE: IL ZIP: 60440 FORMER COMPANY: FORMER CONFORMED NAME: Fortress Value Acquisition Corp. II DATE OF NAME CHANGE: 20200622 8-K 1 brhc10038737_8k.htm 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


 
FORM 8-K


 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act Of 1934
 
Date of Report (Date of earliest event reported): June 24, 2022



ATI PHYSICAL THERAPY, INC.
(Exact name of registrant as specified in its charter)
 


Delaware
001-39439
85-1408039
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

790 Remington Boulevard
Bolingbrook, Illinois
 
60440
(Address of principal executive offices)
 
(Zip Code)

(630) 296-2223
(Registrant’s telephone number, including area code)
 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class
 
Trading
Symbol
 
Name of Each Exchange
on Which Registered
Class A Common Stock, $0.0001 par value
 
ATIP
 
New York Stock Exchange
Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
 
ATIP WS
 
New York Stock Exchange
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 


Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
Effective July 8, 2022, Joe Zavalishin, Chief Development Officer, will resign from the Company.  Under the terms of his employment agreement, the Company and Mr. Zavalishin are to enter into a mutual release pursuant to which Mr. Zavalishin will be eligible for the following payments and benefits: (i) 1.25x the sum of his base salary and target bonus in 2022, paid over 15 months from the date of termination; (ii) a prorated bonus for the current year, based on actual performance in accordance with the Company's Annual Incentive Bonus plan, paid at the time bonuses are paid to other employees; (iii) continued coverage of health benefits for up to 12 months, if elected; and (iv) the vesting of all unvested grants of equity compensation made to him pursuant to the Wilco Acquisition LP 2016 Equity Incentive Plan.
 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: June 24, 2022
ATI Physical Therapy, Inc.
     
 
By:
/s/ Joseph Jordan
 
Name:
Joseph Jordan
 
Title:
Chief Financial Officer



EX-101.SCH 2 atip-20220624.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 atip-20220624_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 4 atip-20220624_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Class of Stock [Domain] Common Stock [Member] Class of Stock [Axis] Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Entity Listings [Table] Entity Listings [Line Items] Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share [Member] EX-101.PRE 5 atip-20220624_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Document and Entity Information
Jun. 24, 2022
Entity Listings [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 24, 2022
Entity Registrant Name ATI PHYSICAL THERAPY, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-39439
Entity Tax Identification Number 85-1408039
Entity Address, Address Line One 790 Remington Boulevard
Entity Address, City or Town Bolingbrook
Entity Address, State or Province IL
Entity Address, Postal Zip Code 60440
City Area Code 630
Local Phone Number 296-2223
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0001815849
Common Stock [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security Class A Common Stock, $0.0001 par value
Trading Symbol ATIP
Security Exchange Name NYSE
Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
Trading Symbol ATIP WS
Security Exchange Name NYSE
XML 7 brhc10038737_8k_htm.xml IDEA: XBRL DOCUMENT 0001815849 2022-06-24 2022-06-24 0001815849 us-gaap:CommonStockMember 2022-06-24 2022-06-24 0001815849 atip:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf1150PerShareMember 2022-06-24 2022-06-24 false 0001815849 8-K 2022-06-24 ATI PHYSICAL THERAPY, INC. DE 001-39439 85-1408039 790 Remington Boulevard Bolingbrook IL 60440 630 296-2223 false false false false Class A Common Stock, $0.0001 par value ATIP NYSE Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share ATIP WS NYSE false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 3 22 1 false 2 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://therapy.atipt.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports brhc10038737_8k.htm atip-20220624.xsd atip-20220624_def.xml atip-20220624_lab.xml atip-20220624_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "brhc10038737_8k.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 3, "dts": { "definitionLink": { "local": [ "atip-20220624_def.xml" ] }, "inline": { "local": [ "brhc10038737_8k.htm" ] }, "labelLink": { "local": [ "atip-20220624_lab.xml" ] }, "presentationLink": { "local": [ "atip-20220624_pre.xml" ] }, "schema": { "local": [ "atip-20220624.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 35, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 1, "memberStandard": 1, "nsprefix": "atip", "nsuri": "http://therapy.atipt.com/20220624", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10038737_8k.htm", "contextRef": "c20220624to20220624", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://therapy.atipt.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10038737_8k.htm", "contextRef": "c20220624to20220624", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "atip_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf1150PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share [Member]" } } }, "localname": "RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf1150PerShareMember", "nsuri": "http://therapy.atipt.com/20220624", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityListingsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Listings [Line Items]" } } }, "localname": "EntityListingsLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityListingsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container for exchange listing information for an entity", "label": "Entity Listings [Table]" } } }, "localname": "EntityListingsTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://therapy.atipt.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 14 0001140361-22-023936-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-22-023936-xbrl.zip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end